Consistent with DNA methylation, this is also the first in vivo study showing that supplementation of Dnmt inhibitors soon after induction of diabetes, or intervention with them during the reversal phase, prevents/ceases progression of diabetic retinopathy. Here, DNMT1 is linked to diabetes mellitus.